November 30, 2024 - 19:08

A. Cornelius Baker, a prominent figure in the fight for H.I.V. testing and the rights of individuals affected by H.I.V. and AIDS, has died at the age of 63. Throughout his career, Baker worked tirelessly both within government agencies and as an advocate in the community, focusing on improving the lives of those impacted by the epidemic, particularly among minority populations.
Baker's commitment to public health and social justice was evident in his efforts to increase awareness and access to H.I.V. testing. He believed that education and outreach were crucial in combating the stigma surrounding H.I.V. and AIDS, especially in marginalized communities. His advocacy work helped to shape policies that aimed to provide better healthcare resources and support for individuals living with the virus.
His legacy will be remembered not only for his professional achievements but also for the compassion and dedication he showed to those he served. Baker's passing marks a significant loss in the ongoing struggle for health equity and the rights of people living with H.I.V. and AIDS.
October 30, 2026 - 22:03
Health Provider Launches Drive-Thru Testing Ahead of Respiratory Illness SeasonA health organization is taking early steps to prepare for the busy respiratory illness season by introducing drive-thru testing for flu, COVID-19, and strep throat at its Council Oak location. The...
October 30, 2026 - 14:37
Why Leadership Has a Bigger Effect on Employee Health Than Many RealizeBy Daniel Butcher Leaders influence not only how organizations perform but also the health and well-being of the people who work in them. That holds true for small companies, medium-sized...
October 29, 2026 - 18:54
Forest and Grasslands Team Pushes Integrated Action at Biodiversity SummitYerevan, Armenia, 30 October 2026 - The Forest and Grasslands Team took part in a wide range of events at the 17th meeting of the Conference of the Parties to the Convention on Biological Diversity...
October 29, 2026 - 14:24
Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock InA top federal health official advocated for a significant shift in medication policy regarding hormone replacement therapies while maintaining a substantial financial stake in a company that stands...